| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antioxidant Therapies for Traumatic Brain Injury
|
Hall, Edward D.
|
|
2010
|
7 |
1 |
p. 51-61
11 p.
|
artikel
|
| 2 |
Antioxidant therapies for traumatic brain injury
|
Hall, Edward D.
|
|
2010
|
7 |
1 |
p. 51-61
|
artikel
|
| 3 |
Antioxidant Therapies for Traumatic Brain Injury
|
Hall, Edward D.
|
|
|
7 |
1 |
p. 51-61
|
artikel
|
| 4 |
Biomarkers for the Diagnosis, Prognosis, and Evaluation of Treatment Efficacy for Traumatic Brain Injury
|
Dash, Pramod K.
|
|
2010
|
7 |
1 |
p. 100-114
15 p.
|
artikel
|
| 5 |
Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury
|
Dash, Pramod K.
|
|
2010
|
7 |
1 |
p. 100-114
|
artikel
|
| 6 |
Biomarkers for the Diagnosis, Prognosis, and Evaluation of Treatment Efficacy for Traumatic Brain Injury
|
Dash, Pramod K.
|
|
|
7 |
1 |
p. 100-114
|
artikel
|
| 7 |
Break and poster viewing
|
|
|
2010
|
7 |
1 |
p. 136-
1 p.
|
artikel
|
| 8 |
Break and poster viewing
|
|
|
|
7 |
1 |
p. 136
|
artikel
|
| 9 |
Calpain as a Therapeutic Target in Traumatic Brain Injury
|
Saatman, Kathryn E.
|
|
2010
|
7 |
1 |
p. 31-42
12 p.
|
artikel
|
| 10 |
Calpain as a therapeutic target in traumatic brain injury
|
Saatman, Kathryn E.
|
|
2010
|
7 |
1 |
p. 31-42
|
artikel
|
| 11 |
Calpain as a Therapeutic Target in Traumatic Brain Injury
|
Saatman, Kathryn E.
|
|
|
7 |
1 |
p. 31-42
|
artikel
|
| 12 |
Cell Death Mechanisms and Modulation in Traumatic Brain Injury
|
Stoica, Bogdan A.
|
|
2010
|
7 |
1 |
p. 3-12
10 p.
|
artikel
|
| 13 |
Cell death mechanisms and modulation in traumatic brain injury
|
Stoica, Bogdan A.
|
|
2010
|
7 |
1 |
p. 3-12
|
artikel
|
| 14 |
Cell Death Mechanisms and Modulation in Traumatic Brain Injury
|
Stoica, Bogdan A.
|
|
|
7 |
1 |
p. 3-12
|
artikel
|
| 15 |
Clinical Trials in Traumatic Brain Injury: Past Experience and Current Developments
|
Maas, Andrew I.R.
|
|
2010
|
7 |
1 |
p. 115-126
12 p.
|
artikel
|
| 16 |
Clinical trials in traumatic brain injury: Past experience and current developments
|
Maas, Andrew I. R.
|
|
2010
|
7 |
1 |
p. 115-126
|
artikel
|
| 17 |
Clinical Trials in Traumatic Brain Injury: Past Experience and Current Developments
|
Maas, Andrew I.R.
|
|
|
7 |
1 |
p. 115-126
|
artikel
|
| 18 |
Contents
|
|
|
2010
|
7 |
1 |
p. ii-iii
nvt p.
|
artikel
|
| 19 |
Contents
|
|
|
|
7 |
1 |
p. ii-iii
|
artikel
|
| 20 |
Editorial Board
|
|
|
2010
|
7 |
1 |
p. i-
1 p.
|
artikel
|
| 21 |
Editorial Board
|
|
|
|
7 |
1 |
p. i
|
artikel
|
| 22 |
IMPACT Recommendations for Improving the Design and Analysis of Clinical Trials in Moderate to Severe Traumatic Brain Injury
|
Maas, Andrew I.R.
|
|
2010
|
7 |
1 |
p. 127-134
8 p.
|
artikel
|
| 23 |
IMPACT recommendations for improving the design and analysis of clinical trials in moderate to severe traumatic brain injury
|
Maas, Andrew I. R.
|
|
2010
|
7 |
1 |
p. 127-134
|
artikel
|
| 24 |
IMPACT Recommendations for Improving the Design and Analysis of Clinical Trials in Moderate to Severe Traumatic Brain Injury
|
Maas, Andrew I.R.
|
|
|
7 |
1 |
p. 127-134
|
artikel
|
| 25 |
Introduction—Introduction and acknowledgments
|
Cha, Jang-Ho
|
|
2010
|
7 |
1 |
p. 135-
1 p.
|
artikel
|
| 26 |
Introduction—Introduction and acknowledgments
|
Cha, Jang-Ho
|
|
|
7 |
1 |
p. 135
|
artikel
|
| 27 |
Involvement of Pro- and Anti-Inflammatory Cytokines and Chemokines in the Pathophysiology of Traumatic Brain Injury
|
Ziebell, Jenna M.
|
|
2010
|
7 |
1 |
p. 22-30
9 p.
|
artikel
|
| 28 |
Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury
|
Ziebell, Jenna M.
|
|
2010
|
7 |
1 |
p. 22-30
|
artikel
|
| 29 |
Involvement of Pro- and Anti-Inflammatory Cytokines and Chemokines in the Pathophysiology of Traumatic Brain Injury
|
Ziebell, Jenna M.
|
|
|
7 |
1 |
p. 22-30
|
artikel
|
| 30 |
Keynote address—FDA Regulation of Stem Cell Therapy
|
Witten, Celia
|
|
2010
|
7 |
1 |
p. 137-
1 p.
|
artikel
|
| 31 |
Keynote address—FDA Regulation of Stem Cell Therapy
|
Witten, Celia
|
|
|
7 |
1 |
p. 137
|
artikel
|
| 32 |
Keynote address—Huntington's Advocacy: Why I Care
|
Roberson, Judy
|
|
2010
|
7 |
1 |
p. 135-
1 p.
|
artikel
|
| 33 |
Keynote address—Huntington's Advocacy: Why I Care
|
Roberson, Judy
|
|
|
7 |
1 |
p. 135
|
artikel
|
| 34 |
Keynote address—Working Toward Mesenchymal Stem Cell Therapy for HD
|
Nolta, Jan
|
|
2010
|
7 |
1 |
p. 136-
1 p.
|
artikel
|
| 35 |
Keynote address—Working Toward Mesenchymal Stem Cell Therapy for HD
|
Nolta, Jan
|
|
|
7 |
1 |
p. 136
|
artikel
|
| 36 |
Mitochondrial Damage: A Target for New Therapeutic Horizons
|
Soustiel, Jean F.
|
|
2010
|
7 |
1 |
p. 13-21
9 p.
|
artikel
|
| 37 |
Mitochondrial damage: A target for new therapeutic horizons
|
Soustiel, Jean F.
|
|
2010
|
7 |
1 |
p. 13-21
|
artikel
|
| 38 |
Mitochondrial Damage: A Target for New Therapeutic Horizons
|
Soustiel, Jean F.
|
|
|
7 |
1 |
p. 13-21
|
artikel
|
| 39 |
Platform presentation—Early Defect of Transforming Growth Factor β1 Formation in Huntington's Disease
|
Battaglia, G.
|
|
2010
|
7 |
1 |
p. 135-136
2 p.
|
artikel
|
| 40 |
Platform presentation—Early Defect of Transforming Growth Factor β1 Formation in Huntington's Disease
|
Battaglia, G.
|
|
|
7 |
1 |
p. 135-136
|
artikel
|
| 41 |
Platform presentation—Early vs Late Huntington's Disease: Is There a Difference in Psychiatric Symptom Severity?
|
Anderson, K.
|
|
2010
|
7 |
1 |
p. 136-
1 p.
|
artikel
|
| 42 |
Platform presentation—Early vs Late Huntington's Disease: Is There a Difference in Psychiatric Symptom Severity?
|
Anderson, K.
|
|
|
7 |
1 |
p. 136
|
artikel
|
| 43 |
Platform presentation—Impairments in Precision Grip Control in Pre-symptomatic Huntington's Disease
|
Rao, A.
|
|
2010
|
7 |
1 |
p. 136-
1 p.
|
artikel
|
| 44 |
Platform presentation—Impairments in Precision Grip Control in Pre-symptomatic Huntington's Disease
|
Rao, A.
|
|
|
7 |
1 |
p. 136
|
artikel
|
| 45 |
Platform presentation—Late-breaking research—Multivariate Clinical Predictors of Huntington Disease (HD): Prospective Results from the PREDICT-HD Study
|
Langbehn, D.
|
|
2010
|
7 |
1 |
p. 137-
1 p.
|
artikel
|
| 46 |
Platform presentation—Late-breaking research—Multivariate Clinical Predictors of Huntington Disease (HD): Prospective Results from the PREDICT-HD Study
|
Langbehn, D.
|
|
|
7 |
1 |
p. 137
|
artikel
|
| 47 |
Poster 15: A Successful Short- and Long-Term Recruiting Strategy for Huntington Clinical Trials: A Community Effort
|
Goodman, L.
|
|
2010
|
7 |
1 |
p. 142-143
2 p.
|
artikel
|
| 48 |
Poster 15: A Successful Short- and Long-Term Recruiting Strategy for Huntington Clinical Trials: A Community Effort
|
Goodman, L.
|
|
|
7 |
1 |
p. 142-143
|
artikel
|
| 49 |
Poster 1: Caregiver Quality of Life in Huntington's Disease
|
Cox, M.
|
|
2010
|
7 |
1 |
p. 138-
1 p.
|
artikel
|
| 50 |
Poster 1: Caregiver Quality of Life in Huntington's Disease
|
Cox, M.
|
|
|
7 |
1 |
p. 138
|
artikel
|
| 51 |
Poster 6: Cerebrospinal Fluid (CSF) Volume Is the Main Marker of Huntington Disease Progression Severity and Age-at-Onset Prediction
|
Squitieri, F.
|
|
2010
|
7 |
1 |
p. 139-140
2 p.
|
artikel
|
| 52 |
Poster 6: Cerebrospinal Fluid (CSF) Volume Is the Main Marker of Huntington Disease Progression Severity and Age-at-Onset Prediction
|
Squitieri, F.
|
|
|
7 |
1 |
p. 139-140
|
artikel
|
| 53 |
Poster 27: Characterizing Psychomotor Declines in Prodromal Huntington Disease with the Trail Making Test
|
O'Rourke, J.
|
|
2010
|
7 |
1 |
p. 147-
1 p.
|
artikel
|
| 54 |
Poster 27: Characterizing Psychomotor Declines in Prodromal Huntington Disease with the Trail Making Test
|
O'Rourke, J.
|
|
|
7 |
1 |
p. 147
|
artikel
|
| 55 |
Poster 10: Degree of Disability Is Predictive of Physical But Not Mental Health Quality of Life in Huntington's Disease
|
Robottom, B.
|
|
2010
|
7 |
1 |
p. 141-
1 p.
|
artikel
|
| 56 |
Poster 10: Degree of Disability Is Predictive of Physical But Not Mental Health Quality of Life in Huntington's Disease
|
Robottom, B.
|
|
|
7 |
1 |
p. 141
|
artikel
|
| 57 |
Poster 28: Delphi Process for the Development of Treatment Guidelines for Behavioral Symptoms and Chorea in Huntington's Disease
|
van Duijn, E.
|
|
2010
|
7 |
1 |
p. 147-
1 p.
|
artikel
|
| 58 |
Poster 28: Delphi Process for the Development of Treatment Guidelines for Behavioral Symptoms and Chorea in Huntington's Disease
|
van Duijn, E.
|
|
|
7 |
1 |
p. 147
|
artikel
|
| 59 |
Poster 7: Early Defect of Transforming Growth Factor β1 Formation in Huntington's Disease
|
Battaglia, G.
|
|
2010
|
7 |
1 |
p. 140-
1 p.
|
artikel
|
| 60 |
Poster 7: Early Defect of Transforming Growth Factor β1 Formation in Huntington's Disease
|
Battaglia, G.
|
|
|
7 |
1 |
p. 140
|
artikel
|
| 61 |
Poster 21: EURO-HDB—The First Large, Comprehensive European Study on the Burden of Huntington's Disease
|
Dorey, J.
|
|
2010
|
7 |
1 |
p. 145-
1 p.
|
artikel
|
| 62 |
Poster 21: EURO-HDB—The First Large, Comprehensive European Study on the Burden of Huntington's Disease
|
Dorey, J.
|
|
|
7 |
1 |
p. 145
|
artikel
|
| 63 |
Poster 14: Evaluation of Novel Radiotracers Targeting Non-Dopaminergic Striatal Biomarkers in HD: 18F-FPEB and PET Imaging for Metabotropic Glutamate Receptor Type 5 (mGluR5) Expression in Healthy Subjects and Subjects with Huntington Disease (HD)
|
Russell, D.
|
|
2010
|
7 |
1 |
p. 142-
1 p.
|
artikel
|
| 64 |
Poster 14: Evaluation of Novel Radiotracers Targeting Non-Dopaminergic Striatal Biomarkers in HD: 18F-FPEB and PET Imaging for Metabotropic Glutamate Receptor Type 5 (mGluR5) Expression in Healthy Subjects and Subjects with Huntington Disease (HD)
|
Russell, D.
|
|
|
7 |
1 |
p. 142
|
artikel
|
| 65 |
Poster 3: Frequency of Epileptic Seizures in a Population of Juvenile Huntington's Disease Patients
|
Cloud, L.
|
|
2010
|
7 |
1 |
p. 138-139
2 p.
|
artikel
|
| 66 |
Poster 3: Frequency of Epileptic Seizures in a Population of Juvenile Huntington's Disease Patients
|
Cloud, L.
|
|
|
7 |
1 |
p. 138-139
|
artikel
|
| 67 |
Poster 16: Genetic Approach to Huntington's Disease Therapeutics
|
MacDonald, M.
|
|
2010
|
7 |
1 |
p. 143-
1 p.
|
artikel
|
| 68 |
Poster 16: Genetic Approach to Huntington's Disease Therapeutics
|
MacDonald, M.
|
|
|
7 |
1 |
p. 143
|
artikel
|
| 69 |
Poster 2: Genetic Discrimination of Individuals at Risk of Huntington's Disease: Further Analysis of the RESPOND-HD Data From Australia (Site 144)
|
Goh, A.
|
|
2010
|
7 |
1 |
p. 138-
1 p.
|
artikel
|
| 70 |
Poster 2: Genetic Discrimination of Individuals at Risk of Huntington's Disease: Further Analysis of the RESPOND-HD Data From Australia (Site 144)
|
Goh, A.
|
|
|
7 |
1 |
p. 138
|
artikel
|
| 71 |
Poster 13: Huntington's Disease Disrupts Motor Control Mechanisms That Rely on Internal Models
|
Cortes, J.C.
|
|
2010
|
7 |
1 |
p. 142-
1 p.
|
artikel
|
| 72 |
Poster 13: Huntington's Disease Disrupts Motor Control Mechanisms That Rely on Internal Models
|
Cortes, J.C.
|
|
|
7 |
1 |
p. 142
|
artikel
|
| 73 |
Poster 18: Lack of Awareness of Motor and Cognitive Phenoconversion in Huntington's Disease
|
Richardson, K.
|
|
2010
|
7 |
1 |
p. 144-
1 p.
|
artikel
|
| 74 |
Poster 18: Lack of Awareness of Motor and Cognitive Phenoconversion in Huntington's Disease
|
Richardson, K.
|
|
|
7 |
1 |
p. 144
|
artikel
|
| 75 |
Poster 25: Longitudinal Analysis of the UHDRS in Individuals At-Risk for Huntington's Disease by Gene Status: The Prospective Huntington's Disease Observational At-Risk Study (PHAROS)
|
|
|
2010
|
7 |
1 |
p. 146-
1 p.
|
artikel
|
| 76 |
Poster 25: Longitudinal Analysis of the UHDRS in Individuals At-Risk for Huntington's Disease by Gene Status: The Prospective Huntington's Disease Observational At-Risk Study (PHAROS)
|
|
|
|
7 |
1 |
p. 146
|
artikel
|
| 77 |
Poster 17: Metabolic Profiling in Non-Human Primate Model of Huntington's Disease Reveals Early Disruptions in Tryptophan Metabolism
|
Johnson, J.
|
|
2010
|
7 |
1 |
p. 143-
1 p.
|
artikel
|
| 78 |
Poster 17: Metabolic Profiling in Non-Human Primate Model of Huntington's Disease Reveals Early Disruptions in Tryptophan Metabolism
|
Johnson, J.
|
|
|
7 |
1 |
p. 143
|
artikel
|
| 79 |
Poster 29: Multivariate Clinical Predictors of Huntington Disease (HD): Prospective Results from the PREDICT-HD Study
|
Langbehn, D.
|
|
2010
|
7 |
1 |
p. 147-
1 p.
|
artikel
|
| 80 |
Poster 29: Multivariate Clinical Predictors of Huntington Disease (HD): Prospective Results from the PREDICT-HD Study
|
Langbehn, D.
|
|
|
7 |
1 |
p. 147
|
artikel
|
| 81 |
Poster 23: Pharmacology of the Dopaminergic Stabilizer Pridopidine (ACR16)
|
Waters, S.
|
|
2010
|
7 |
1 |
p. 145-146
2 p.
|
artikel
|
| 82 |
Poster 23: Pharmacology of the Dopaminergic Stabilizer Pridopidine (ACR16)
|
Waters, S.
|
|
|
7 |
1 |
p. 145-146
|
artikel
|
| 83 |
Poster 20: Pridopidine (ACR16) in Huntington's Disease: An Update on the MermaiHD and HART Studies
|
Tedroff, J.
|
|
2010
|
7 |
1 |
p. 144-145
2 p.
|
artikel
|
| 84 |
Poster 20: Pridopidine (ACR16) in Huntington's Disease: An Update on the MermaiHD and HART Studies
|
Tedroff, J.
|
|
|
7 |
1 |
p. 144-145
|
artikel
|
| 85 |
Poster 8: Reliability of the Problem Behaviours Assessment for HD (short version)–Data From the TRACK-HD Study
|
Callaghan, J.
|
|
2010
|
7 |
1 |
p. 140-
1 p.
|
artikel
|
| 86 |
Poster 8: Reliability of the Problem Behaviours Assessment for HD (short version)–Data From the TRACK-HD Study
|
Callaghan, J.
|
|
|
7 |
1 |
p. 140
|
artikel
|
| 87 |
Poster 12: Self-Efficacy in Health Behaviors: Is There a Difference in Huntington vs Parkinson Disease?
|
Mitchell, A.
|
|
2010
|
7 |
1 |
p. 141-142
2 p.
|
artikel
|
| 88 |
Poster 12: Self-Efficacy in Health Behaviors: Is There a Difference in Huntington vs Parkinson Disease?
|
Mitchell, A.
|
|
|
7 |
1 |
p. 141-142
|
artikel
|
| 89 |
Poster 11: Striatal Volume Distinguishes Converters from Non-Converters: Findings from PREDICT-HD
|
Aylward, E.
|
|
2010
|
7 |
1 |
p. 141-
1 p.
|
artikel
|
| 90 |
Poster 11: Striatal Volume Distinguishes Converters from Non-Converters: Findings from PREDICT-HD
|
Aylward, E.
|
|
|
7 |
1 |
p. 141
|
artikel
|
| 91 |
Poster 4: The Effect of Video Game-Based Exercise on Dynamic Balance and Mobility in Individuals with Huntington's Disease
|
Kegelmeyer, D.
|
|
2010
|
7 |
1 |
p. 139-
1 p.
|
artikel
|
| 92 |
Poster 4: The Effect of Video Game-Based Exercise on Dynamic Balance and Mobility in Individuals with Huntington's Disease
|
Kegelmeyer, D.
|
|
|
7 |
1 |
p. 139
|
artikel
|
| 93 |
Poster 22: The Huntington Self-Assessment Instrument (HSAI): A Comprehensive and Specific Tool to Measure the Burden of Huntington's Disease
|
Tedroff, J.
|
|
2010
|
7 |
1 |
p. 145-
1 p.
|
artikel
|
| 94 |
Poster 22: The Huntington Self-Assessment Instrument (HSAI): A Comprehensive and Specific Tool to Measure the Burden of Huntington's Disease
|
Tedroff, J.
|
|
|
7 |
1 |
p. 145
|
artikel
|
| 95 |
Poster 9: The Short Version of the Problem Behaviours Assessment for HD (PBA-s): An Item Response Analysis Using Data from the TRACK-HD Study
|
Evans, K.
|
|
2010
|
7 |
1 |
p. 140-
1 p.
|
artikel
|
| 96 |
Poster 9: The Short Version of the Problem Behaviours Assessment for HD (PBA-s): An Item Response Analysis Using Data from the TRACK-HD Study
|
Evans, K.
|
|
|
7 |
1 |
p. 140
|
artikel
|
| 97 |
Poster 5: Usefulness of Two Brief Cognitive Screening Measures in Huntington's Disease
|
Lessig, S.
|
|
2010
|
7 |
1 |
p. 139-
1 p.
|
artikel
|
| 98 |
Poster 5: Usefulness of Two Brief Cognitive Screening Measures in Huntington's Disease
|
Lessig, S.
|
|
|
7 |
1 |
p. 139
|
artikel
|
| 99 |
Poster 19: Validation of the Modified Motor Score (mMS): A Subscale of the Unified Huntington's Disease Rating Scale (UHDRS) Motor Score
|
Waters, S.
|
|
2010
|
7 |
1 |
p. 144-
1 p.
|
artikel
|
| 100 |
Poster 19: Validation of the Modified Motor Score (mMS): A Subscale of the Unified Huntington's Disease Rating Scale (UHDRS) Motor Score
|
Waters, S.
|
|
|
7 |
1 |
p. 144
|
artikel
|
| 101 |
Poster viewing
|
|
|
2010
|
7 |
1 |
p. 135-
1 p.
|
artikel
|
| 102 |
Poster viewing
|
|
|
|
7 |
1 |
p. 135
|
artikel
|
| 103 |
Poster 26: Word Reading Compared to Demographics-Based Estimates of Premorbid IQ in Early Huntington Disease
|
Adams, W.
|
|
2010
|
7 |
1 |
p. 146-147
2 p.
|
artikel
|
| 104 |
Poster 26: Word Reading Compared to Demographics-Based Estimates of Premorbid IQ in Early Huntington Disease
|
Adams, W.
|
|
|
7 |
1 |
p. 146-147
|
artikel
|
| 105 |
Poster 24: Worry and Experience of Genetic Discrimination in Persons at Risk for Huntington Disease
|
Erwin, C.
|
|
2010
|
7 |
1 |
p. 146-
1 p.
|
artikel
|
| 106 |
Poster 24: Worry and Experience of Genetic Discrimination in Persons at Risk for Huntington Disease
|
Erwin, C.
|
|
|
7 |
1 |
p. 146
|
artikel
|
| 107 |
Statins in Traumatic Brain Injury
|
Wible, Elissa F.
|
|
2010
|
7 |
1 |
p. 62-73
12 p.
|
artikel
|
| 108 |
Statins in traumatic brain injury
|
Wible, Elissa F.
|
|
2010
|
7 |
1 |
p. 62-73
|
artikel
|
| 109 |
Statins in Traumatic Brain Injury
|
Wible, Elissa F.
|
|
|
7 |
1 |
p. 62-73
|
artikel
|
| 110 |
Substance P Antagonists as a Therapeutic Approach to Improving Outcome Following Traumatic Brain Injury
|
Vink, Robert
|
|
2010
|
7 |
1 |
p. 74-80
7 p.
|
artikel
|
| 111 |
Substance P antagonists as a therapeutic approach to improving outcome following traumatic brain injury
|
Vink, Robert
|
|
2010
|
7 |
1 |
p. 74-80
|
artikel
|
| 112 |
Substance P Antagonists as a Therapeutic Approach to Improving Outcome Following Traumatic Brain Injury
|
Vink, Robert
|
|
|
7 |
1 |
p. 74-80
|
artikel
|
| 113 |
The Evidence for Hypothermia as a Neuroprotectant in Traumatic Brain Injury
|
Dietrich, W. Dalton
|
|
2010
|
7 |
1 |
p. 43-50
8 p.
|
artikel
|
| 114 |
The evidence for hypothermia as a neuroprotectant in traumatic brain injury
|
Dietrich, W. Dalton
|
|
2010
|
7 |
1 |
p. 43-50
|
artikel
|
| 115 |
The Evidence for Hypothermia as a Neuroprotectant in Traumatic Brain Injury
|
Dietrich, W. Dalton
|
|
|
7 |
1 |
p. 43-50
|
artikel
|
| 116 |
Third Annual Huntington Disease Clinical Research Symposium
|
Dubinsky, Richard
|
|
2010
|
7 |
1 |
p. 135-147
|
artikel
|
| 117 |
Traumatic Brain Injury and Aging: Is a Combination of Progesterone and Vitamin D Hormone a Simple Solution to a Complex Problem?
|
Cekic, Milos
|
|
2010
|
7 |
1 |
p. 81-90
10 p.
|
artikel
|
| 118 |
Traumatic brain injury and aging: Is a combination of progesterone and vitamin D hormone a simple solution to a complex problem?
|
Cekic, Milos
|
|
2010
|
7 |
1 |
p. 81-90
|
artikel
|
| 119 |
Traumatic Brain Injury and Aging: Is a Combination of Progesterone and Vitamin D Hormone a Simple Solution to a Complex Problem?
|
Cekic, Milos
|
|
|
7 |
1 |
p. 81-90
|
artikel
|
| 120 |
Traumatic Brain Injury: Therapeutic Challenges and New Directions
|
Vink, Robert
|
|
2010
|
7 |
1 |
p. 1-2
2 p.
|
artikel
|
| 121 |
Traumatic brain injury: Therapeutic challenges and new directions
|
Vink, Robert
|
|
2010
|
7 |
1 |
p. 1-2
|
artikel
|
| 122 |
Traumatic Brain Injury: Therapeutic Challenges and New Directions
|
Vink, Robert
|
|
|
7 |
1 |
p. 1-2
|
artikel
|
| 123 |
Use of Magnesium in Traumatic Brain Injury
|
Sen, Ananda P.
|
|
2010
|
7 |
1 |
p. 91-99
9 p.
|
artikel
|
| 124 |
Use of magnesium in traumatic brain injury
|
Sen, Ananda P.
|
|
2010
|
7 |
1 |
p. 91-99
|
artikel
|
| 125 |
Use of Magnesium in Traumatic Brain Injury
|
Sen, Ananda P.
|
|
|
7 |
1 |
p. 91-99
|
artikel
|
Tijdschrift beschrijving